Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zyomyx and Speciality search for disease profiles:

This article was originally published in Clinica

Executive Summary

Zyomyx and Speciality Laboratories are to collaborate on a programme to discover new patterns of disease markers that have greater clinical use than traditional single-analyte tests. Zyomyx' Protein Profiling Biochip platform, which can measure dozens of analytes in a drop of fluid, will be combined with Speciality's large archive of biological samples and diagnostic results to help discover the markers, says Zyomyx, of Hayward, California. Speciality will obtain exclusive rights to provide in-house testing services based on any disease marker profiles resulting for the collaboration, and will pay Zyomyx royalties for these testing services. Zyomyx retains the rights to other fields of use.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065026

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel